Trials / Completed
CompletedNCT01076738
Screening DIVA - Diffuse Vascular Disease
The Value of Routine Screening for Diffuse Vascular Disease in the Canadian Post-Acute Coronary Syndrome/Ischemic Stroke/Transient Ischemic Attack General Practice Population With Previously Undocumented Peripheral Arterial Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,233 (estimated)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary Objective: To investigate the value of the Edinburgh Claudication Questionnaire (ECQ) against the ankle-brachial index (ABI) in Canadian patients mainly followed in general practice, with documented acute coronary syndrome (ACS)/ischemic stroke (IS)/transient ischemic attack (TIA) and who are not known to have peripheral arterial disease (PAD) at the time of enrolment. Secondary Objective: To collect data on the prevalence of PAD in this population as measured by ABI.
Conditions
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-02-26
- Last updated
- 2010-09-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01076738. Inclusion in this directory is not an endorsement.